Skip to main content

Table 3 Sociodemographic characteristics, vaccination types, comorbidities, and completion rate for each survey

From: Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project

Baseline characteristics

n

%

N

2199

100

Gender

 Female

1233

56

 Male

0965

43

 Diverse

0001

01

Year of birth

 1991–2003 (approx. 18–30 years)

0419

19

 1971–1990 (approx. 31–50 years)

0772

35

 1951–1970 (approx. 51–70 years)

0859

39

 1933–1950 (approx. 70–88 years)

0149

07

Residence

 Rural areaa

0618

28

 Small townb

0642

29

 Medium-sized townc

0223

10

 Cityd

0716

33

Employment

 Employed

1525

69

 In education

0228

10

 Unemployed

0050

02

 Retired

0336

15

 Other

0040

02

 Not specified

0020

01

Education

 No degree

0002

01

 Lower certificate

0055

02

 Intermediate certificate

0273

12

 Complete apprenticeship

0321

15

 High school diploma

0459

21

 University degree

1047

48

 Not specified

0042

02

Vaccination

 Control group

0024

01

 Covid-19

2175

99

First vaccination COVID (n = 2175)

 BNT162b2 (BioNTech/Pfizer)

1313

60

 mRNA-1273 (Moderna)

0253

12

 ChadOx1 (AstraZeneca)

0609

28

 Ad26.COV2.S (Johnson & Johnson)

0000

00

Second vaccination COVID (n = 1753)

 BNT162b2 (BioNTech/Pfizer)

1200

68

 mRNA-1273 (Moderna)

0375

21

 ChadOx1 (AstraZeneca)

0141

08

 Ad26.COV2.S (Johnson & Johnson)

0000

00

 Cancelled

0005

01

 Not planned

0032

02

NA

0422

 

Health status

 No preexisting diseases

0832

38

 Allergies

0598

27

 Hypertension

0408

19

 Back pain

0331

15

 Lung disease

0187

9

 Rheumatism/autoimmune disease

0172

8

 Depression

0153

7

 Osteoarthritis

0142

6

 Gastrointestinal disease

0135

6

 Heart disease

0117

5

 Diabetes

0094

4

 Cancer

0072

3

 Coagulation problems

0044

2

 Kidney disease

0040

2

 Liver disease

0034

2

 Anaemia

0028

1

 

Mean

SD

mSCQ-D (n = 2199)e

0001.6

02.4

BMI (n = 2176)f

0026.2

05.8

  1. aRural area, < 5000. bSmall town, 5000 to approx. 20,000. cMedium-sized town, 20,000 to approx. 100,000. dCity, 100,000 or more inhabitants. emSCQ-D, modified German version of the Self-Administered Comorbidity Questionnaire consisting of the diseases listed above. fBMI, body mass index